Combination therapy vs monotherapy
Serious adverse events · people with primary hypertension
It is very uncertain whether combination therapy changes serious adverse events compared with monotherapy (very low certainty).
1 finding from 1 review
- First‐line combination therapy versus first‐line monotherapy for primary hypertension 2020 · Cochrane Headline outcomes onlyRR 0.77 [0.31, 1.92]3 studies · 568 participantsVery low